Phase I trial of the anti-Lewis Y drug immunoconjugate BR96-doxorubicin in patients with Lewis Y-expressing epithelial tumors

  • Mansoor N. Saleh
  • , Steve Sugarman
  • , James Murray
  • , Joy B. Ostroff
  • , Diane Healey
  • , Dennie Jones
  • , Carol R. Daniel
  • , Donna LeBherz
  • , Hannah Brewer
  • , Nicole Onetto
  • , Albert F. LoBuglio

Research output: Contribution to journal › Article › peer-review

172 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase I trial of the anti-Lewis Y drug immunoconjugate BR96-doxorubicin in patients with Lewis Y-expressing epithelial tumors'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science